This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Chiba University, Fuso Pharmaceutical Industries, Ltd.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2017
Title: Tomohito Sadahiro: Innovator in Drug Solutions
Introduction
Tomohito Sadahiro is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug solutions for dialysis and acute blood purification. With a total of 2 patents, his work has the potential to improve patient care and treatment outcomes.
Latest Patents
One of Sadahiro's latest inventions is a stable bicarbonate ion-containing drug solution. This innovative solution is designed for dialysis, enhancing stability through the inclusion of phosphate ions. The invention also addresses the need for a drug solution used in acute blood purification, specifically a dialysate and substitution liquid that can be mixed before use. This formulation prevents the formation of insoluble fine particles or precipitates over time, thereby avoiding complications such as hypokalemia and hypophosphatemia.
Career Highlights
Throughout his career, Tomohito Sadahiro has worked with esteemed institutions, including Chiba University and Fuso Pharmaceutical Industries, Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
Sadahiro has collaborated with notable colleagues such as Shigeto Oda and Masataka Nakamura. These partnerships have contributed to the advancement of his research and innovations in the pharmaceutical field.
Conclusion
Tomohito Sadahiro's contributions to drug solutions highlight his commitment to improving healthcare through innovation. His patents reflect a deep understanding of the complexities involved in drug formulation, ultimately benefiting patients in need of effective treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile